7Baggers
 Published on: 2025-09-29 11:35:53  newser.com Mon, 29 Sep 2025 16:35:53 GMT
 Published on: 2025-09-29 00:27:57  newser.com Mon, 29 Sep 2025 05:27:57 GMT
 wells fargo initiates coverage on mist with overweight rating |  GuruFocus Thu, 11 Sep 2025 07:00:00 GMT
 layoff tracker: ac immune to cut 30% of workforce  biospace.com Fri, 05 Sep 2025 07:00:00 GMT

Milestone Pharmaceuticals Inc
(NASDAQ:MIST) 

MIST stock logo

Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. It is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the Uni...

Full Time Employees: 28
CEO: Joseph G. Oliveto  
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends